Davide Leone & Partners Investment CO Ltd. Neurocrine Biosciences Inc Transaction History

Davide Leone & Partners Investment CO Ltd.

$0
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $2.33 Million - $2.67 Million	-26,091 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $673,238 - $917,947	7,688 Added 41.78%	26,091 $2.54 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $1.6 Million - $1.99 Million	18,403 New	18,403 $1.76 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.98 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.39 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$718 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$359 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$260 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account